Navigation Links
PharmaPoint: Multiple Sclerosis - United Kingdom Drug Forecast and Market Analysis to 2022
Date:5/16/2013

matic Therapies 274.3 United Kingdom 284.3.1 Diagnosis 284.3.2 Clinical Practice 285 Competitive Assessment 305.1 Overview 305.2 Strategic Competitor Assessment 315.3 Product Profiles – Major Brands 335.3.1 Betaseron/Betaferon (interferon beta-1b) 335.3.2 Avonex (interferon beta-1a) 385.3.3 Rebif (interferon beta-1a) 435.3.4 Copaxone (glatiramer acetate; copolymer-1) 475.3.5 Tysabri (natalizumab) 515.3.6 Gilenya/Imusera (fingolimod; FTY720) 565.3.7 Aubagio (teriflunomide) 615.3.8 Other Disease–Modifying Therapies 666 Opportunity and Unmet Need 676.1 Overview 676.2 Unmet Needs 686.2.1 Currently Available MS Drugs Only Provide Partial Benefits 686.2.2 The High Cost of MS Drugs Could Continue to Price out Patients 696.2.3 Safety and Tolerability of Therapy is Undermined by Side Effects 706.2.4 Effective Treatments for Progressive MS Are Still Elusive 716.2.5 Inconvenient Route of Administration and Frequent Dosing Limits Compliance 726.2.6 The Lack of Predictive Biomarkers Delays MS Diagnosis 736.3 Unmet Needs Gap Analysis 746.4 Opportunities 756.4.1 Treatments for Progressive MS 756.4.2 Targeting Patients with Clinically Isolated Syndrome 757 Pipeline Assessment 767.1 Overview 767.2 Promising Drugs in Clinical Development 787.2.1 BG-12 (dimethyl fumarate; BG00012) 807.2.2 Lemtrada (alemtuzumab) 857.2.3 Laquinimod (ABR-215062) 917.2.4 Daclizumab High-Yield Process (HYP) 967.2.5 Ocrelizumab (RG1594) 1017.2.6 Siponimod (BAF-312) 1067.2.7 NU-100 (interferon beta-1b) 1107.2.8 Masitinib (AB-1010) 1147.2.9 Tcelna (imilecleucel-T) 1188 Market Outlook 1228.1 United Kingdom 1228.1.1 Forecast 1228.1.2 Key Events 1268.1.3 Drivers and Barriers 1279 Appendix 1299.1 Bibliography 1299.2 Abbreviations 1409.3 Methodology 1449.4 Forecasting Methodology 1449.4.1 Diagnosed MS patients 1449.4.2 Percent Drug-Treated Patients 1459.4.3 Drugs Included in Each Therapeutic Class 1459.4.4 Launch and Pat
'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. PharmaPoint: Multiple Sclerosis - US Drug Forecast and Market Analysis to 2022
2. PharmaPoint: Multiple Sclerosis - China Drug Forecast and Market Analysis to 2022
3. PharmaPoint: Osteoporosis - US Drug Forecast and Market Analysis to 2022
4. PharmaPoint: Osteoporosis - India Drug Forecast and Market Analysis to 2022
5. ASCO 2013: Boehringer Ingelheim to Present Data Across Multiple Cancers, Including Different Treatment Settings for Advanced NSCLC
6. Food Recalls Driven by Companies Issuing Multiple Recalls in the First Quarter of 2013, According to Latest ExpertRECALL Index
7. In Relapsed/Refractory Multiple Myeloma, Thought Leaders Are Optimistic that the Combination of Carfilzomib, Lenalidomide and Dexamethasone Will Be the Most Efficacious Regimen
8. Hobart Group Holdings Marks 10th Anniversary With Multiple Milestones
9. Mapi Pharma Granted United States Patent Covering Glatiramer Depot for Multiple Sclerosis
10. For Pharma Companies, Launching Multiple Similar Products Can Be a "Good Problem" but Requires Smart Resourcing
11. Deploying an Effective Pay for Performance Bonus System that Works Across Multiple Industry Sectors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... Pa. , Aug. 27, 2015  PinnacleHealth CardioVascular Institute ... and second in the United States ... new type of stent for blockages in the main artery ... within the artery and potentially less risk for stent fracture ... is a prospective, single-arm, multicenter clinical trial of the BioMimics ...
(Date:8/27/2015)... Aug. 27, 2015  Lightwave Logic, Inc. (OTCQB: ... of Next Generation Photonic Devices and Non-Linear ... high speed fiber-optic data communications and optical computing, ... has been appointed to the Company,s Board of ... field of optoelectronics is widely recognized with wide-ranging ...
(Date:8/27/2015)... , Aug. 27, 2015  CytomX Therapeutics, ... the treatment of cancer, today announced that ... the company,s Board of Directors, has been appointed ... at Eli Lilly and AstraZeneca, and also oversaw ... approved checkpoint inhibitor, at Bristol-Myers Squibb and the ...
Breaking Medicine Technology:First Pennsylvania Patient Treated in Landmark Vascular Study 2Lightwave Logic Announces the Appointment of Optoelectronics Industry Leader, Michael Lebby, Ph.D. to its Board of Directors 2Lightwave Logic Announces the Appointment of Optoelectronics Industry Leader, Michael Lebby, Ph.D. to its Board of Directors 3Immuno-Oncology Veteran Rachel Humphrey, M.D., Joins CytomX as Chief Medical Officer 2Immuno-Oncology Veteran Rachel Humphrey, M.D., Joins CytomX as Chief Medical Officer 3
... Reportlinker.com announces that a new market research ... Global Kidney Stone Management ... http://www.reportlinker.com/p0611035/Global-Kidney-Stone-Management-Devices-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_D This report analyzes ... Devices in US$ Million by the following ...
... RMD ) announced today that it will be presenting ... Conference at the Grand Hyatt in New York City on September ... Grand Hyatt in New York City on September 20, 2011; ... in Phoenix, AZ on November 9, 2011; Piper Jaffray Healthcare ...
Cached Medicine Technology:Global Kidney Stone Management Devices Industry 2Global Kidney Stone Management Devices Industry 3Global Kidney Stone Management Devices Industry 4Global Kidney Stone Management Devices Industry 5Global Kidney Stone Management Devices Industry 6Global Kidney Stone Management Devices Industry 7Global Kidney Stone Management Devices Industry 8Global Kidney Stone Management Devices Industry 9Global Kidney Stone Management Devices Industry 10Global Kidney Stone Management Devices Industry 11ResMed Inc. to Present at Upcoming Conferences 2
(Date:8/27/2015)... ... August 27, 2015 , ... Thriveology Founders, Dr. Carly Letzt Carney and ... Amazing Aging Expo in Denver, Colorado on Saturday, August 29, 2015 at the Marriott ... media outlets as health authorities, and will present a two part seminar entitled, “How ...
(Date:8/27/2015)... ... August 27, 2015 , ... On May 30th, 2015, at the ... as sponsor of the “Music With A Mission” benefit concert. For the past two ... programs in the underfunded school districts of Mendon and neighboring town, Quincy, IL. Organized ...
(Date:8/27/2015)... , ... August 27, 2015 , ... The Naderi Center ... be offering Kybella, a cutting-edge, noninvasive procedure to improve submental fat. The first ... provides permanent results without surgery. Dr. Kulak is the only Board Certified surgeon ...
(Date:8/27/2015)... CA (PRWEB) , ... August 27, 2015 , ... Healthpointe ... into its La Tijera Clinic in Los Angeles. Licensed to practice Chinese Needle Therapy ... emphasis on neuromuscular injuries and diseases. Dr. Priebe also practices in Healthpointe’s La Mirada ...
(Date:8/27/2015)... (PRWEB) , ... August 27, 2015 , ... In addition ... Alvernia University now offers a third doctoral program at its main campus in Reading: ... a terminal degree program designed to prepare advanced practice nurses for the highest level ...
Breaking Medicine News(10 mins):Health News:Internationally-renowned Naturopathic Doctor and Chiropractor Team up to Reveal Secrets of Avoiding Disease 2Health News:Best Drug Rehabilitation Interviews Madd Hoss Jackson at the 2015 "Music With A Mission" Benefit Concert 2Health News:Noninvasive Double Chin Elimination Now Available in Herndon and Chevy Chase 2Health News:Noninvasive Double Chin Elimination Now Available in Herndon and Chevy Chase 3Health News:Qualified Medical Examiner and Acupuncturist Joins Healthpointe in Los Angeles 2Health News:Qualified Medical Examiner and Acupuncturist Joins Healthpointe in Los Angeles 3Health News:Alvernia University Now Offering Three Doctoral Degree Programs 2
... ... Center published in Brain Injury, the official journal of the International Brain Injury Association, ... (TBI). Cognitive fatigue has been shown to be one of the most challenging symptoms ... ...
... , DENVER, June 11 Birner Dental Management Services, ... of PERFECT TEETH dental practices, announced its regular ... a quarterly cash dividend of 17 cents per share of ... to shareholders of record June 26, 2009. , , ...
... external defibrillators , , WASHINGTON, June 11 In ... (SCA), The Richard B. and Lynne V. Cheney Cardiovascular Institute ... ReStart DC program on June 11. The goal of the ... where large numbers of people gather throughout all eight wards ...
... to Stem Growing Healthcare Coverage Shortfalls - , , WASHINGTON, ... 1221, "The Medicare Prompt Pay Correction Act," a companion ... of Representatives and currently has 45 co-sponsors. , , ... Pat Roberts (R-KS). The bill is a step forward in addressing ...
... His Life , , DALLAS, June 11 In his ... but later years and the pressure of being a father and ... depression Bresee created the poetry of his book, "The Hidden Story: ... ). , , "Depression and addictions brought me to a ...
... /PRNewswire-FirstCall/ - MDS Inc. (TSX: MDS; NYSE: MDZ ... global life sciences markets, today reported financial results for the ... MDS reported total revenue of $282 million, a net loss ... for the second quarter of 2009. These results include a ...
Cached Medicine News:Health News:Kessler Foundation Research Center Study Provides Insight into One of the Most Challenging Symptoms Following a Traumatic Brain Injury 2Health News:Kessler Foundation Research Center Study Provides Insight into One of the Most Challenging Symptoms Following a Traumatic Brain Injury 3Health News:ReStart DC Launches Life-Saving Public Access Defibrillation Program 2Health News:ReStart DC Launches Life-Saving Public Access Defibrillation Program 3Health News:Senate Bill to Protect Patients' Healthcare by Amending Medicare Coverage 2Health News:Senate Bill to Protect Patients' Healthcare by Amending Medicare Coverage 3Health News:'The Hidden Story': Poetry Inspired by Author's Struggle with Depression, Addiction 2Health News:MDS Reports Second Quarter 2009 Financial Results 2Health News:MDS Reports Second Quarter 2009 Financial Results 3Health News:MDS Reports Second Quarter 2009 Financial Results 4Health News:MDS Reports Second Quarter 2009 Financial Results 5Health News:MDS Reports Second Quarter 2009 Financial Results 6Health News:MDS Reports Second Quarter 2009 Financial Results 7Health News:MDS Reports Second Quarter 2009 Financial Results 8Health News:MDS Reports Second Quarter 2009 Financial Results 9Health News:MDS Reports Second Quarter 2009 Financial Results 10Health News:MDS Reports Second Quarter 2009 Financial Results 11Health News:MDS Reports Second Quarter 2009 Financial Results 12Health News:MDS Reports Second Quarter 2009 Financial Results 13Health News:MDS Reports Second Quarter 2009 Financial Results 14Health News:MDS Reports Second Quarter 2009 Financial Results 15Health News:MDS Reports Second Quarter 2009 Financial Results 16Health News:MDS Reports Second Quarter 2009 Financial Results 17Health News:MDS Reports Second Quarter 2009 Financial Results 18Health News:MDS Reports Second Quarter 2009 Financial Results 19
... The Zeus Scientific, Inc. ENA Profile-6 ... for the detection of IgG antibodies to ... in human sera. When performed according to ... autoantibody profile may aid in the diagnosis ...
Inquire...
... K-ASSAY Microalbumin Urine Controls are ... use liquid requiring no reconstitution ... from human urine, fortified to ... and creatinine. Preservatives including sodium ...
The K-ASSAY ITA Lyophilized Multi-Control Set is intended to be used as a consistent test sample of known concentration for monitoring the performance of K-ASSAY immunoturbidimetric assays for the li...
Medicine Products: